Sudden Loss of Vision – History and Examination
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Un-Explained Visual Loss Following Silicone Oil Removal
Roca et al. Int J Retin Vitr (2017) 3:26 DOI 10.1186/s40942-017-0079-6 International Journal of Retina and Vitreous ORIGINAL ARTICLE Open Access Un‑explained visual loss following silicone oil removal: results of the Pan American Collaborative Retina Study (PACORES) Group Jose A. Roca1, Lihteh Wu2* , Maria Berrocal3, Francisco Rodriguez4, Arturo Alezzandrini5, Gustavo Alvira6, Raul Velez‑Montoya7, Hugo Quiroz‑Mercado7, J. Fernando Arevalo8, Martín Serrano9, Luiz H. Lima10, Marta Figueroa11, Michel Farah10 and Giovanna Chico1 Abstract Purpose: To report the incidence and clinical features of patients that experienced un-explained visual loss following silicone oil (SO) removal. Methods: Multicenter retrospective study of patients that underwent SO removal during 2000–2012. Visual loss of 2 lines was considered signifcant. ≥ Results: A total of 324 eyes of 324 patients underwent SO removal during the study period. Forty two (13%) eyes sufered a signifcant visual loss following SO removal. Twenty three (7.1%) of these eyes lost vision secondary to known causes. In the remaining 19 (5.9%) eyes, the loss of vision was not explained by any other pathology. Eleven of these 19 patients (57.9%) were male. The mean age of this group was 49.2 16.4 years. Eyes that had an un-explained visual loss had a mean IOP while the eye was flled with SO of 19.6 6.9 mm± Hg. The length of time that the eye was flled with SO was 14.8 4.4 months. In comparison, eyes that± did not experience visual loss had a mean IOP of 14 7.3 mm Hg (p < 0.0002)± and a mean tamponade duration of 9.3 10.9 months (p < 0.0001). -
URGENT/EMERGENT When to Refer Financial Disclosure
URGENT/EMERGENT When to Refer Financial Disclosure Speaker, Amy Eston, M.D. has a financial interest/agreement or affiliation with Lansing Ophthalmology, where she is employed as a ophthalmologist. 58 yr old WF with 6 month history of decreased vision left eye. Ache behind the left eye for 2-3 months. Using husband’s contact lens solution made it feel better. Seen by two eye care professionals. Given glasses & told eye exam was normal. No past ocular history Medical history of depression Takes only aspirin and vitamins 20/20 OD 20/30 OS Eye Pressure 15 OD 16 OS – normal Dilated fundus exam & slit lamp were normal Pupillary exam was normal Extraocular movements were full Confrontation visual fields were full No red desaturation Color vision was slightly decreased but the same in both eyes Amsler grid testing was normal OCT disc – OD normal OS slight decreased RNFL OCT of the macula was normal Most common diagnoses: Dry Eye Optic Neuritis Treatment - copious amount of artificial tears. Return to recheck refraction Visual field testing Visual Field testing - Small defect in the right eye Large nasal defect in the left eye Visual Field - Right Hemianopsia. MRI which showed a subacute parietal and occipital lobe infarct. ANISOCORIA Size of the Pupil Constrictor muscles innervated by the Parasympathetic system & Dilating muscles innervated by the Sympathetic system The Sympathetic System Begins in the hypothalamus, travels through the brainstem. Then through the upper chest, up through the neck and to the eye. The Sympathetic System innervates Mueller’s muscle which helps to elevate the upper eyelid. -
Pattern of Vitreo-Retinal Diseases at the National Referral Hospital in Bhutan: a Retrospective, Hospital-Based Study Bhim B
Rai et al. BMC Ophthalmology (2020) 20:51 https://doi.org/10.1186/s12886-020-01335-x RESEARCH ARTICLE Open Access Pattern of vitreo-retinal diseases at the national referral hospital in Bhutan: a retrospective, hospital-based study Bhim B. Rai1,2* , Michael G. Morley3, Paul S. Bernstein4 and Ted Maddess1 Abstract Background: Knowing the pattern and presentation of the diseases is critical for management strategies. To inform eye-care policy we quantified the pattern of vitreo-retinal (VR) diseases presenting at the national referral hospital in Bhutan. Methods: We reviewed all new patients over three years from the retinal clinic of the Jigme Dorji Wangchuck National Referral Hospital. Demographic data, presenting complaints and duration, treatment history, associated systemic diseases, diagnostic procedures performed, and final diagnoses were quantified. Comparisons of the expected and observed frequency of gender used Chi-squared tests. We applied a sampling with replacement based bootstrap analysis (10,000 cycles) to estimate the population means and the standard errors of the means and standard error of the 10th, 25th, 50th, 75th and 90th percentiles of the ages of the males and females within 20-year cohorts. We then applied t-tests employing the estimated means and standard errors. The 2913 subjects insured that the bootstrap estimates were statistically conservative. Results: The 2913 new cases were aged 47.2 ± 21.8 years. 1544 (53.0%) were males. Housewives (953, 32.7%) and farmers (648, 22.2%) were the commonest occupations. Poor vision (41.9%), screening for diabetic and hypertensive retinopathy (13.1%), referral (9.7%), sudden vision loss (9.3%), and trauma (8.0%) were the commonest presenting symptoms. -
Diabetic Retinopathy
Postgrad MedJ7 1998;74:129-1 33 C The Fellowship of Postgraduate Medicine, 1998 Classic diseases revisited Postgrad Med J: first published as 10.1136/pgmj.74.869.129 on 1 March 1998. Downloaded from Diabetic retinopathy David A Infeld, John G O'Shea Summary Diabetes mellitus is the most common cause of blindness amongst the 25-65 Diabetic retinopathy is the com- year age group. The ocular complications of diabetes include diabetic monest cause ofblindness amongst retinopathy, iris neovascularisation, glaucoma, cataract, and microvascular individuals of working age. The abnormalities of the optic nerve. The most frequent complication is diabetic onset of retinopathy is variable. retinopathy.`' The risk of becoming blind increases with the duration of Regular ophthalmic screening is diabetes. The cumulative risk is higher in insulin-dependent diabetes mellitus essential in order to detect treat- (IDDM) than in noninsulin dependent diabetes mellitus (NIDDM).4 able lesions early. Retinal laser World-wide, it is estimated that over 2.5 million people are blind due to diabetes, therapy is highly effective in slow- which is thus the fourth leading cause ofblindness and an increasing problem in ing the progression of retinopathy developing nations.6 and in preventing blindness. As the Blindness commonly occurs from either macular oedema or ischaemia, vitre- sufferers of diabetes mellitus, the ous haemorrhage, or tractional retinal detachment.''5 Macular oedema is now commonest endocrine disorder, the leading cause of loss of vision amongst Western patients. It develops earlier now constitute approximately and is more severe in NIDDM than in IDDM.7 The treatment of macular 1-2% of Western populations, con- oedema has therefore been the subject of leading international studies. -
Acute Hydrops Following Penetrating Keratoplasty in a Keratoconic Patient
Acute Hydrops following PK • Baradaran-Rafiee et al Iranian Journal of Ophthalmology • Volume 20 • Number 4 • 2008 Acute Hydrops following Penetrating Keratoplasty in a Keratoconic Patient Alireza Baradaran-Rafiee, MD1 • Manijeh Mahdavi, MD2 • Sepehr Feizi, MD3 Abstract Purpose: To report a case with history of penetrating keratoplasty (PK) for keratoconus that developed acute hydrops in the recipient and donor cornea Methods: A 46-year-old man, with history of bilateral keratoconus, who had undergone corneal transplantation in his left eye, presented with complaints of sudden visual reduction, photophobia, redness and pain of the left eye. Results: Review of his clinical course, slit-lamp biomicroscopy, laboratory evaluations including confocal microscopy and ultrasound biomicroscopy revealed acute hydrops in the graft. Second corneal transplantation was done for his left eye and pathologic examination confirmed the diagnosis. Conclusion: Acute hydrops can occur after PK in patients with keratoconus. Although this condition is not common, it should be considered as a differential diagnosis of graft rejection. Keywords: Acute Hydrops, Keratoconus, Corneal Transplantation Iranian Journal of Ophthalmology 2008;20(4):49-53 Introduction Keratoconus is a degenerative, One of the complications of advanced non-inflammatory disease of the cornea, with keratoconus is acute hydrops. Affected onset generally at puberty. It is progressive in patients suffer from acute visual loss with pain 20% of cases and can be treated by lamellar and photophobia. On slit-lamp examination, or penetrating keratoplasty (PK). Its incidence conjunctival hyperemia and diffuse corneal in general population is reported to be about edema with intrastromal cystic spaces are 1/2000.1 Changes in corneal collagen visible. -
Transient Monocular Visual Loss
Transient Monocular Visual Loss VALÉRIE BIOUSSE, MD AND JONATHAN D. TROBE, MD ● PURPOSE: To provide a practical update on the diagno- when most episodes of TMVL do not cause total loss of sis and management of transient monocular visual loss vision.2 (TMVL). The most important step in evaluating a patient with ● DESIGN: Perspective. visual loss is to establish whether the visual loss is ● METHODS: Review of the literature. monocular or binocular.2,5 Monocular visual loss always ● RESULTS: TMVL is an important clinical symptom. It results from lesions anterior to the chiasm (the eye or the has numerous causes but most often results from tran- optic nerve), whereas binocular visual loss results from sient retinal ischemia. It may herald permanent visual lesions of both eyes or optic nerves, or, more likely, of the loss or a devastating stroke, and patients with TMVL chiasm or retrochiasmal visual pathway. should be evaluated urgently. A practical approach to the Deciding whether an episode of abrupt visual loss evaluation of the patient with TMVL must be based on occurred in one eye or both is not always easy. Very few the patient’s age and the suspected underlying etiology. patients realize that binocular hemifield (homonymous) In the older patient, tests should be performed to inves- visual field loss affects the fields of both eyes. They will tigate giant cell arteritis, atherosclerotic large vessel usually localize it to the eye that lost its temporal field. The disease, and cardiac abnormalities. In the younger pa- best clues to the fact that visual loss was actually binocular tient, TMVL is usually benign and the evaluation should are reading impairment (monocular visual loss does not be tailored to the particular clinical setting. -
Updates on Myopia
Updates on Myopia A Clinical Perspective Marcus Ang Tien Y. Wong Editors Updates on Myopia Marcus Ang • Tien Y. Wong Editors Updates on Myopia A Clinical Perspective Editors Marcus Ang Tien Y. Wong Singapore National Eye Center Singapore National Eye Center Duke-NUS Medical School Duke-NUS Medical School National University of Singapore National University of Singapore Singapore Singapore This book is an open access publication. ISBN 978-981-13-8490-5 ISBN 978-981-13-8491-2 (eBook) https://doi.org/10.1007/978-981-13-8491-2 © The Editor(s) (if applicable) and The Author(s) 2020, corrected publication 2020 Open Access This book is licensed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license and indicate if changes were made. The images or other third party material in this book are included in the book's Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the book's Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specifc statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. -
Myopia Dystopia Are Future Generations Doomed to an Ever-Worsening Spiral of Refractive Error?
NOVEMBER / DECEMBER 2013 # 03 Upfront In Practice NextGen Profession Blindingly Obvious Progress Predicting Outcomes of Stem Cells in Ophthalmology: How To Do Your Own With Glaucoma Anti-VEGF Therapy Are We Nearly There Yet? Market Research 10 26 – 28 35 – 37 40 – 41 Myopia Dystopia Are future generations doomed to an ever-worsening spiral of refractive error? 16 – 20 RETINAL DISEASE IS OUR FOCUS At Alimera Sciences, we are dedicated to developing innovative, vision-improving treatments for chronic retinal diseases. Our commitment to retina-treating ophthalmologists and their patients is manifest in a product portfolio designed to treat early- and late-stage diseases such as DMO, wet and dry AMD, and RVO.* Moving the back of the eye to the forefront of research and development. © 2013 Alimera Sciences Limited Date of preparation: March 2013 ILV-00182 * DMO-diabetic macular oedema; AMD-age-related macular degeneration; RVO-retinal vein occlusion. Online this Month Is Print Dead? Clearly not. You’re reading this... But that’s not to say there isn’t room for some exciting digital publishing, as proved by The Ophthalmologist iPad app. Here, we take you on a whistle-stop tour of the navigation features. Swipe left/right to the previous/next article Swipe up/down to read an article Formatted for landscape & portrait Go back to last read article Access the issues archive Quick access to all articles in issue Add an article to your favorites Full issue easy preview Interactive Icons: More information available More content available Or visit us on the web at www.theophthalmologist.com Contents 14 Feature 16 Myopia Dystopia Five questions that must be answered on the causes and consequences of near-sightedness, By Richard Gallagher 24 In Practice 03 Online This Month Upfront 24 Loss of Traction Mark Hillen asks if orcriplasmin 10 Blindingly Obvious Progress can.. -
Red Spot • Important Is the Time Period from the Event • Therapy Is Reasonable If the Patient Is Treated Within the First 6 Hours
ACUTE VISUAL LOSS KAROLÍNA SKORKOVSKÁ VISUAL LOSS • CENTRAL RETINAL ARTERY OCCLUSION • CENTRAL RETINAL VEIN OCCLUSION • RETINAL DETACHMENT • VITREOUS HAEMORRHAGE • OPTIC NEURITIS • AION VISUAL LOSS - PATIENT´S HISTORY • UNILATERAL / BILATERAL • SUDDEN / SLOWLY PROGRESSIVE • PAIN • COMPLAINTS (FOGGY VISION, FLOATERS, CURTAIN…) • OTHER SYMPTOMS (FEVER, WEIGHT LOSS, REFRACTIVE CHANGE, …) CATARACT • SLOWLY PROGRESSIVE VISUAL LOSS • FOGGY VISION • CHANGE IN REFRACTIVE ERROR (INDEX MYOPIA) • CATARACT VISIBLE ON SLIT LAMP • THERAPY: CATARACT EXTRACTION RETINAL ARTERY OCCLUSION • SUDDEN, UNILATERAL, PAINLESS LOSS OF VISION • VISUAL ACUITY MAY BE „NO LIGHT PERCEPTION“ • BRANCH / CENTRAL RETINAL ARTERY OCCLUSION • RETINAL ISCHEMIA WITH CHERRY RED SPOT • IMPORTANT IS THE TIME PERIOD FROM THE EVENT • THERAPY IS REASONABLE IF THE PATIENT IS TREATED WITHIN THE FIRST 6 HOURS RETINAL ARTERY OCCLUSION - COMPLICATIONS • POOR PROGNOSIS • PERMANENT LOSS OF VISION • OPTIC DISC ATROPHY • NEOVASCULARISATION GLAUCOMA RETINAL ARTERY OCCLUSION - THERAPY • LOWERING OF INTRAOCULAR PRESSURE • RETROBULBAR INJECTION OF VASODILATORS • PARACENTHESIS • SYSTEMIC TROMBOLYSIS (DEPARTMENT OF INTERNAL MEDICINE) • CHECK-UP OF RISK FACTORS OF ISCHEMIA / TROMBOSIS RETINAL VEIN OCCLUSION • SUDDEN, PAINLESS, UNILATERAL VISUAL LOSS • VISUAL ACUITY USUALLY NOT AS MUCH AFFECTED AS IN CRAO • BRANCH / CENTRAL RETINAL VEIN OCCLUSION • OFTEN CARDIOVASCULAR RISK FACTORS (HYPERTENSION, DIABETES, HYPERLIPIDEMIA, ISCHEMIC HEART DISEASE,…) • RETINAL HAEMORHAGES, OPTIC NERVE HEAD OEDEMA, RETINAL -
A Review of Central Retinal Artery Occlusion: Clinical Presentation And
Eye (2013) 27, 688–697 & 2013 Macmillan Publishers Limited All rights reserved 0950-222X/13 www.nature.com/eye 1 2 1 2 REVIEW A review of central DD Varma , S Cugati , AW Lee and CS Chen retinal artery occlusion: clinical presentation and management Abstract Central retinal artery occlusion (CRAO) is an that in turn place an individual at risk of future ophthalmic emergency and the ocular ana- cerebral stroke and ischaemic heart disease. logue of cerebral stroke. Best evidence reflects Although analogous to a cerebral stroke, there that over three-quarters of patients suffer is currently no guideline-endorsed evidence for profound acute visual loss with a visual acuity treatment. Current options for therapy include of 20/400 or worse. This results in a reduced the so-called ‘standard’ therapies, such as functional capacity and quality of life. There is sublingual isosorbide dinitrate, systemic also an increased risk of subsequent cerebral pentoxifylline or inhalation of a carbogen, stroke and ischaemic heart disease. There are hyperbaric oxygen, ocular massage, globe no current guideline-endorsed therapies, compression, intravenous acetazolamide and although the use of tissue plasminogen acti- mannitol, anterior chamber paracentesis, and vator (tPA) has been investigated in two methylprednisolone. None of these therapies randomized controlled trials. This review will has been shown to be better than placebo.5 describe the pathophysiology, epidemiology, There has been recent interest in the use of and clinical features of CRAO, and discuss tissue plasminogen activator (tPA) with two current and future treatments, including the recent randomized controlled trials on the 1Flinders Comprehensive use of tPA in further clinical trials. -
Eleventh Edition
SUPPLEMENT TO April 15, 2009 A JOBSON PUBLICATION www.revoptom.com Eleventh Edition Joseph W. Sowka, O.D., FAAO, Dipl. Andrew S. Gurwood, O.D., FAAO, Dipl. Alan G. Kabat, O.D., FAAO Supported by an unrestricted grant from Alcon, Inc. 001_ro0409_handbook 4/2/09 9:42 AM Page 4 TABLE OF CONTENTS Eyelids & Adnexa Conjunctiva & Sclera Cornea Uvea & Glaucoma Viitreous & Retiina Neuro-Ophthalmic Disease Oculosystemic Disease EYELIDS & ADNEXA VITREOUS & RETINA Blow-Out Fracture................................................ 6 Asteroid Hyalosis ................................................33 Acquired Ptosis ................................................... 7 Retinal Arterial Macroaneurysm............................34 Acquired Entropion ............................................. 9 Retinal Emboli.....................................................36 Verruca & Papilloma............................................11 Hypertensive Retinopathy.....................................37 Idiopathic Juxtafoveal Retinal Telangiectasia...........39 CONJUNCTIVA & SCLERA Ocular Ischemic Syndrome...................................40 Scleral Melt ........................................................13 Retinal Artery Occlusion ......................................42 Giant Papillary Conjunctivitis................................14 Conjunctival Lymphoma .......................................15 NEURO-OPHTHALMIC DISEASE Blue Sclera .........................................................17 Dorsal Midbrain Syndrome ..................................45 -
Internuclear Ophthalmoplegia and Horner's Syndrome Due To
362 Journal of the Royal Society of Medicine Volume 86 June 1993 Internuclear ophthalmoplegia and Her erythrocyte sedimentation rate (ESR) was 105 in the Horner's syndrome due to presumed first hour, the white blood cell count was 11.1 x109/l, giant cell arteritis platelets 475x 109/1, the blood film showed some target cells and ++ rouleaux. Her alkaline phosphatase was 226 and her 7y-glutamine transferase 102. A computerized tomography scan reported atrophic changes in the cerebral hemispheres, and an old infarct was noted in the left temporal lobe. Within Ayman Askari MRCP1 0 M P Jolobe FRCP2 6 days of starting treatment the headache improved remarkably, and in the following 2 months the patient D I Shepherd FRCP2 'Princess Royal Hospital; maintained her progress with no change in the neurological Telford, Shropshire and 2Tameside General Hospital signs. The ESR was 47 within 8 days of admission and 3 by Ashton-under-Lyne, Lancashire day 38 of starting treatment. Keywords: giant cell arteritis; ophthalmoplegia; Horner's syndrome; Discussion ataxic nystagmus Our aim is to draw attention to the association between neuro-ophthalmic signs and presumed GCA. Leukocytosis, abnormal latex fixation test and fever are in keeping with cell arteritis is an inflammatory, the diagnosis. It is likely that many patients with GCA have Giant (GCA) occlusive ophthalmoplegia in the course of their illness and failure arteriopathy of unknown aetiology. It is common in the to detect it may be due to the transient nature of this elderly, with an incidence of 17.4 per 100 000 ofthe popula- manifestation3.